Introgen Therapeutics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Introgen Therapeutics

INGN 6.850

+2.1%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (701)	3/30/2007 12:27:50 PM
From: Jibacoa	Read Replies (2) of 802

Yes,we need to propose or nominate Celia Witten,PhD., M.D. as FDA Director.<g> She has stated before that she doesn't want to create a situation where patients cannot get the products that they need and that may benefit them. She was also in the FDA's committee that recommended lifting the silicone breast implants ban in spite of all the trial lawyers stories & theories.<g> Provenge, "failed" on its primary end point in 2 trials, but a "second look" at the data revealed a 4Ms survival benefit in one of them.In the past, advisory panels and the FDA have rejected cancer drugs in similar situations. Do you think that if the FDA approves Provenge on May 15, it could signal a change in FDA's past policy ? RAGL Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next